Healthcare
PHC Mogla brings healthcare closer to Rajouri's remote villages
PHC Mogla now offers essential healthcare services locally. Residents previously traveled long distances for basic medical treatment. A portable X-ray machine aids emergency care for injured patients. Maternal healthcare has also seen significant local improvements. This facility has become a crucial lifeline for remote villagers.
Sculpt, lift, glow: Face fitness is having a moment in India
Face fitness is emerging as a new category in India’s beauty and wellness market, blending facial massage, muscle stimulation and skincare into studio-led treatments. Premium brands and homegrown players are expanding as consumers seek non-invasive alternatives to aesthetic procedures, driven by growing interest in wellness, grooming and preventive beauty.
Aster DM Quality Care to invest Rs 1,315 crore in Karnataka
Aster DM Quality Care will invest Rs 1,315 crore in Karnataka's healthcare infrastructure. This significant investment aims to strengthen the state's medical facilities and services. The company plans to develop new hospitals and expand existing ones in Bengaluru. These developments will enhance access to advanced tertiary and quaternary care. The commitment underscores Aster's long-term confidence in Karnataka's healthcare ecosystem.
India's Manipal Health to spend $414.4 million to expand capacity
Manipal Health Enterprises plans to investRs 4,000 croreover the next 3–4 years to add2,400 hospital beds, expanding its capacity by over 18%, ahead of its IPO next week. The Temasek-backed hospital chain is also targeting a valuation of up to$8 billionand aims to becomenet debt-freeusing IPO proceeds.
ASG shareholder approaches NCLT against co-founder, alleges oppression
In her petition at the Mumbai NCLT under Sections 241 and 242 of the Companies Act, Gang sought to restrain the company from amending its Articles of Association (AoA) to facilitate a proposed ₹450-crore financing deal by Singhvi for investing in ASG Hospitals, contending that the move violates contractual protections granted to her as a minority shareholder.
Almost all countries overuse antibiotics, contributing to drug resistance: Analysis
A new study reveals most nations overuse stronger 'watch' antibiotics, fueling resistance issues. Researchers developed a framework to assess antibiotic use appropriateness for countries. Globally, around 43 billion antibiotic courses were needed in 2019. Nearly three-quarters of countries used more antibiotics overall than expected. India's actual antibiotic use exceeded its estimated optimal levels significantly.
India contributes one-third of global oral cancer burden; early detection key to survival, says oral cancer expert
India contends with a pressing oral cancer crisis, with thousands of new diagnoses and deaths emerging annually. The predominant factor behind this disease is the consumption of tobacco in diverse forms. Early detection via screening plays a critical role in managing and treating oral cancers successfully. It’s vital to monitor potentially malignant disorders closely and seek rapid medical assistance for ongoing oral health issues.
Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India
India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in India during the first half of 2027. Qdenga offers protection against all four dengue virus serotypes for individuals aged four to sixty. The vaccine demonstrated significant efficacy in late-stage trials, reducing cases and hospitalisations. Takeda is also partnering with Biological E to boost global manufacturing capacity for Qdenga.
Alcon to step up India investments; focus on innovation, training, says Senior Vice Prez Rajkumar Narayanan
Alcon is significantly increasing its investments in India's eye care market. The company sees India as a crucial emerging growth market for its future. Rising eye disorders among younger Indians are a key driver for Alcon's expansion. Alcon plans to enhance innovation and surgeon training programs across the nation. Future manufacturing in India is also being actively evaluated by the company.
Screens are straining young eyes, and Alcon sees India's opportunity
Alcon is increasing investments in India, recognizing its significant emerging market potential. The company focuses on innovation and surgeon training to address rising eye care needs. India's large population and growing myopia present substantial future growth opportunities. Alcon aims to enable advanced cataract care for millions by the year 2030. The global eye care leader is also evaluating future manufacturing possibilities within India.
RECENT NEWS
- PHC Mogla brings healthcare closer to Rajouri's remote villages
- Pedro Pascal talks about Reed Richards and Dr Doom’s connection
- David Jonsson welcomed by Winston Duke for 'Black Panther 3'
- DMK demands immediate NEET ban, seeks probe into Jantar Mantar violence
- Katrina set to make her comeback with 'Spirit'? Fact Check
